**Study of EYP-1901 for Wet Age-Related Macular Degeneration (wAMD)** This study is testing a new treatment called EYP-1901 for people with wet age-related macular degeneration (wAMD), a condition that affects the eye and can cause vision loss. The study compares EYP-1901 with another treatment called Aflibercept to see which works better. To join the study, you must have been diagnosed with wAMD in the eye being studied. You can either have had treatment before or not. Your vision needs to be within a certain range, as measured by a special eye test. If you have received other treatments for wAMD before, you should have had at least two injections in the last six months. Unfortunately, if there's significant damage or scarring in the center of your retina, you can't join. **Key Points:** - **Duration:** The study lasts for 2 years, with the main results checked after about 1 year (56 weeks). - **Visits:** Participants will need to visit the study center for regular check-ups and treatment. - **Risks:** As with any medical study, there may be risks or side effects, which will be explained by the study doctors.